Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,770 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.
Clark JR, Busse PM, Norris CM Jr, Andersen JW, Dreyfuss AI, Rossi RM, Poulin MD, Colevas AD, Tishler RB, Costello R, Lucarini JW, Lucarini D, Thornhill L, Lackey M, Peters E, Posner MR. Clark JR, et al. Among authors: peters e. J Clin Oncol. 1997 Sep;15(9):3100-10. doi: 10.1200/JCO.1997.15.9.3100. J Clin Oncol. 1997. PMID: 9294473
Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
Colevas AD, Busse PM, Norris CM, Fried M, Tishler RB, Poulin M, Fabian RL, Fitzgerald TJ, Dreyfuss A, Peters ES, Adak S, Costello R, Barton JJ, Posner MR. Colevas AD, et al. Among authors: peters es. J Clin Oncol. 1998 Apr;16(4):1331-9. doi: 10.1200/JCO.1998.16.4.1331. J Clin Oncol. 1998. PMID: 9552034 Clinical Trial.
A Phase 1 randomized trial of homologous and heterologous filovirus vaccines with a late booster dose.
Rostad CA, Yildirim I, Kao C, Yi J, Kamidani S, Peters E, Stephens K, Gibson T, Hsiao HM, Singh K, Spearman P, McCracken C, Agbakoba V, Tomashek KM, Goll JB, Gelber CE, Johnson RA, Lee S, Maner-Smith K, Bosinger S, Ortlund EA, Chen X, Anderson LJ, Wrammert J, Suthar M, Rouphael N, Anderson EJ. Rostad CA, et al. Among authors: peters e. NPJ Vaccines. 2024 Dec 23;9(1):255. doi: 10.1038/s41541-024-01042-4. NPJ Vaccines. 2024. PMID: 39715748 Free PMC article.
Impact of the CAPTURE COPD Screening Tool in US Primary Care: A Cluster Randomized Trial.
Martinez FJ, Yawn BP, Angulo D, Lopez C, Murray S, Mannino D, Anderson S, Dolor R, Elder N, Joo M, Khan I, Knox LM, Meldrum C, Peters E, Spino C, Tapp H, Thomashow B, Zittleman L, Brown R, Make B, Han MK; CAPTURE study group. Martinez FJ, et al. Among authors: peters e. Am J Respir Crit Care Med. 2024 Dec 23. doi: 10.1164/rccm.202405-0921OC. Online ahead of print. Am J Respir Crit Care Med. 2024. PMID: 39715575
Correction: Optimising AVATAR therapy for people who hear distressing voices: study protocol for the AVATAR2 multi-centre randomised controlled trial.
Garety P, Edwards CJ, Ward T, Emsley R, Huckvale M, McCrone P, Rus-Calafell M, Fornells-Ambrojo M, Gumley A, Haddock G, Bucci S, McLeod H, Hardy A, Peters E, Myin-Germeys I, Craig T. Garety P, et al. Among authors: peters e. Trials. 2024 Dec 17;25(1):816. doi: 10.1186/s13063-024-08550-7. Trials. 2024. PMID: 39690413 Free PMC article. No abstract available.
1,770 results